AMP Capital Investors Ltd raised its stake in Medidata Solutions Inc (NASDAQ:MDSO) by 57.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 44,120 shares of the company’s stock after acquiring an additional 16,020 shares during the quarter. AMP Capital Investors Ltd’s holdings in Medidata Solutions were worth $2,796,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Polen Capital Management LLC bought a new stake in shares of Medidata Solutions during the third quarter worth $205,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Medidata Solutions by 48.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,242 shares of the company’s stock worth $205,000 after purchasing an additional 1,056 shares during the last quarter. Zions Bancorporation bought a new stake in shares of Medidata Solutions during the third quarter worth $256,000. Brown Advisory Securities LLC bought a new stake in shares of Medidata Solutions during the fourth quarter worth $356,000. Finally, MANA Advisors LLC bought a new stake in shares of Medidata Solutions during the fourth quarter worth $419,000. Institutional investors own 97.52% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other Medidata Solutions news, CFO Rouven Bergmann sold 2,000 shares of the stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $66.46, for a total value of $132,920.00. Following the transaction, the chief financial officer now owns 87,775 shares of the company’s stock, valued at $5,833,526.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Tarek Sherif sold 26,836 shares of the stock in a transaction dated Monday, March 12th. The shares were sold at an average price of $70.25, for a total value of $1,885,229.00. The disclosure for this sale can be found here. Insiders have sold 35,836 shares of company stock worth $2,495,689 in the last ninety days. 5.80% of the stock is currently owned by insiders.

Medidata Solutions stock opened at $67.07 on Thursday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.49 and a current ratio of 1.49. Medidata Solutions Inc has a one year low of $54.91 and a one year high of $85.92. The stock has a market capitalization of $3,876.82, a price-to-earnings ratio of 90.64, a PEG ratio of 3.44 and a beta of 1.56.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Thursday, February 8th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.10. Medidata Solutions had a return on equity of 11.59% and a net margin of 8.14%. The business had revenue of $141.20 million for the quarter, compared to analyst estimates of $140.65 million. During the same quarter in the prior year, the firm posted $0.33 earnings per share. The firm’s revenue for the quarter was up 13.4% compared to the same quarter last year. analysts forecast that Medidata Solutions Inc will post 0.93 EPS for the current fiscal year.

Several analysts have recently commented on MDSO shares. Wells Fargo upgraded Medidata Solutions from a “market perform” rating to an “outperform” rating and set a $80.00 target price on the stock in a report on Friday, December 1st. Deutsche Bank started coverage on Medidata Solutions in a report on Friday, December 8th. They set a “buy” rating and a $78.00 target price on the stock. TheStreet cut Medidata Solutions from a “b” rating to a “c+” rating in a report on Thursday, December 14th. Zacks Investment Research cut Medidata Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, December 27th. Finally, BidaskClub upgraded Medidata Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, January 16th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and eleven have given a buy rating to the company’s stock. Medidata Solutions currently has a consensus rating of “Buy” and an average price target of $82.07.

TRADEMARK VIOLATION WARNING: This report was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.watchlistnews.com/amp-capital-investors-ltd-has-2-80-million-holdings-in-medidata-solutions-inc-mdso/1955139.html.

Medidata Solutions Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.